EdX

Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes (edX)

Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes (edX)

Drugs are biologically active compounds. Drug discovery and drug development rely on methods for measuring biological activity. The term “activity” is quite general. In practice, a substance’s biological activity can refer to how a substance affects a biological pathway, cell-level responses, safety risks, how long a substance resides within in a system, as well as a substance’s effects in an organism (called pharmacodynamics). The design of methods for measuring activity is a critical aspect of drug discovery. The design of robust and informative methods can accelerate the drug discovery and development process.

Class Deals by MOOC List - Click here and see EdX's Active Discounts, Deals, and Promo Codes.

In this course about measuring biological activity, students will learn different methods of activity measurement encountered at different stages of a drug program. The three-week course starts with an introduction to drug targets, which are biological molecules affected by drugs. The second week emphasizes biochemical, cellular, and computational methods for determining the extent to which a drug can affect the action of its target and associated signal pathways. In the final week, students will transition to in vivo studies and the interpretation of dose-response curves.
Students in the course should understand the concepts of proteins and biological pathways. Students should also be comfortable with algebraic expressions, including logarithmic functions. The course is designed in modules. Each module opens with a short video on a selected topic. The module continues with a short reading or exercise with an assessment activity. Each module will require approximately 1 hour to complete, and the course includes 15 modules. Two approaches to the course are recommended. One, a student might spend an hour per day on the course and complete all 15 modules in approximately three weeks. Two, a student with additional available time may be able to work through the entire course in just a single week or over an extended weekend.
Students signed up for the Audit Track have access to the instructional video materials. Students enrolled through the Verified Track have access to the instructional videos, the readings and activities, the assessments, as well as selected additional videos related to the primary instructional videos.

What you'll learn

  • the general idea of target-based drug discovery, in which a drug’s action on a target alters the function of a biological pathway
  • common types of biological molecules that serve as drug targets, especially enzymes and receptors
  • different outcomes of drug-target interactions, including inhibitors, agonists, inverse agonists, and antagonists
  • representative biochemical and cellular methods for measuring drug-target binding
  • types of outcomes used to determine the success of clinical trials
  • the generation and interpretation of dose-response curves

Syllabus

week 1
pathways, targets, and responses
mechanism of action, mode of action, and indication
types of targets and ligands
enzyme and receptor activity curves
potency vs. efficacy

week 2
types of assays
binding assays
in silico assays and screens
functional in vitro assays
comparing potency values

week 3
in vivo preclinical studies
what are biomarkers?
outcomes and surrogate endpoints
dose-response curves
using assays to discover new drugs

Go to Class
MOOC List is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Related Courses

Fundamentals of Good Clinical Practice: Prep and Personnel (Coursera) Coursera
Novartis

Fundamentals of Good Clinical Practice: Prep and Personnel (Coursera)

Welcome to 'Fundamentals of Good Clinical Practice: Prep and Personnel'! This course is designed to introduce you to preparing for a clinical trial. This is Course Two in the Clinical Trial Teams series - the first course 'Introduction to Good Clinical Practice' provides background on what clinical trials are as well as the basic principles and practices of GCP. If you are new to the world of clinical research, we suggest starting your journey with Course One.

Jul 27th 2026
3 Weeks
Introduction to Small Molecule Drug Discovery & Development (Coursera) Coursera
University of Cape Town

Introduction to Small Molecule Drug Discovery & Development (Coursera)

What does it take to advance a new drug from the laboratory bench to the patient’s bedside? Historically, drugs were discovered serendipitously and were usually isolated from natural sources. Today, drug discovery efforts take many years and cost hundreds of millions of dollars. They also require the input of dozens of specialists from a multitude of backgrounds to ensure that therapeutic molecules are efficacious and safe.

Aug 17th 2026
4 Weeks
Introduction to Pharmacokinetics: From ADME to PK/PD (edX) EdX
Davidson College,DavidsonX

Introduction to Pharmacokinetics: From ADME to PK/PD (edX)

A critical aspect of a drug involves how a drug is dosed and circulates throughout the body of a patient. These qualities are aspects of a drug’s pharmacokinetics or PK. Pharmacokinetics encompasses how a drug is absorbed and flows through a patient until it is ultimately eliminated. While pharmacokinetics covers drug behavior in a living organism, PK properties can often be predicted through laboratory tests for a compound’s ADME properties. ADME stands for absorption, distribution, metabolism, and excretion. The PK and ADME properties of potential drug are closely monitored throughout the discovery and early development stages of a drug campaign.

Self Paced
Self-Paced
Introduction to Good Clinical Practice (Coursera) Coursera
Novartis

Introduction to Good Clinical Practice (Coursera)

Welcome to 'Introduction to Good Clinical Practice'! This course is designed to introduce you to the basic principles and practices of Good Clinical Practice (GCP), which are essential for conducting clinical trials and ensuring the safety and well-being of human subjects. Whether you are new to the field or seeking to refresh your knowledge, this course and its coming sequel, 'Fundamentals of Good Clinical Practice' will equip you with the necessary skills and understanding to begin to navigate the complex world of clinical research.

Aug 3rd 2026
3 Weeks
Drug Commercialization (Coursera) Coursera
University of California, San Diego

Drug Commercialization (Coursera)

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success.

Aug 17th 2026
4 Weeks
Take Your Medicine: Developing New Drug Products (edX) EdX
University of Texas at Austin,UTAustinX

Take Your Medicine: Developing New Drug Products (edX)

Discover how new drugs are developed, tested, approved and marketed. Medicine has eradicated or eased the symptoms of many diseases. This course reveals how new drugs go from research innovation to a medicine that can be prescribed to patients. You’ll learn the process, challenges and issues in developing pharmaceutical products.

No sessions available
4 Weeks
Case Studies in Personalized Medicine (Coursera) Coursera
Vanderbilt University

Case Studies in Personalized Medicine (Coursera)

Learn how advances in biomedicine hold the potential to revolutionize drug development, drug treatments, and disease prevention: where are we now, and what does the future hold? This course will present short primers in genetics and mechanisms underlying variability in drug responses. A series of case studies will be used to illustrate principles of how genetics are being brought to bear on refining diagnoses and on personalizing treatment in rare and common diseases. The ethical and operational issues around how to implement large scale genomic sequencing in clinical practice will be addressed.

Aug 17th 2026
5-12 Weeks
Preclinical Safety: From In Vitro Assays to Human Dose Predictions (edX) EdX
Davidson College,DavidsonX

Preclinical Safety: From In Vitro Assays to Human Dose Predictions (edX)

Drugs are approved based on their “safety and efficacy”. Determining the safety of a drug occurs through studies that are largely completely separate from efficacy studies. The safety studies fall under the umbrella of preclinical safety. While a drug’s therapeutic benefit is typically narrow and well-defined, the potential safety risks of a compound can be very broad. Preclinical studies therefore search broadly in order to reveal any possible safety issues in a compound. Safety studies ultimately determine dosing limits for clinical trials as well as the final approved drug product.

Self Paced
Self-Paced